The FDA has given marketing approval to the Prometra II 40-mL programmable pump and its associated programmer software (Flowonix Medical Inc). This system approval expands the reservoir size options to include both 20- and 40-mL pumps, and includes the claim of a 10-year battery life at average flow rates. The Prometra II 40-mL programmable pump is designed to operate identically to the previously approved 20-mL pump, “which has shown clinical benefits for many of the 7,000 patients
DECEMBER 11, 2019